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Abstract
The ubiquitin-proteasome system plays a central role in cellular regulation and protein quality control (PQC). The system is
built as a pyramid of increasing complexity, with two E1 (ubiquitin activating), few dozen E2 (ubiquitin conjugating) and
several hundred E3 (ubiquitin ligase) enzymes. By collecting and analyzing E3 sequences from the KEGG BRITE database and
literature, we assembled a coherent dataset of 563 human E3s and analyzed their various physical features. We found an
increase in structural disorder of the system with multiple disorder predictors (IUPred – E1: 5.97%, E2: 17.74%, E3: 20.03%).
E3s that can bind E2 and substrate simultaneously (single subunit E3, ssE3) have significantly higher disorder (22.98%) than
E3s in which E2 binding (multi RING-finger, mRF, 0.62%), scaffolding (6.01%) and substrate binding (adaptor/substrate
recognition subunits, 17.33%) functions are separated. In ssE3s, the disorder was localized in the substrate/adaptor binding
domains, whereas the E2-binding RING/HECT-domains were structured. To demonstrate the involvement of disorder in E3
function, we applied normal modes and molecular dynamics analyses to show how a disordered and highly flexible linker in
human CBL (an E3 that acts as a regulator of several tyrosine kinase-mediated signalling pathways) facilitates long-range
conformational changes bringing substrate and E2-binding domains towards each other and thus assisting in ubiquitin
transfer. E3s with multiple interaction partners (as evidenced by data in STRING) also possess elevated levels of disorder
(hubs, 22.90% vs. non-hubs, 18.36%). Furthermore, a search in PDB uncovered 21 distinct human E3 interactions, in 7 of
which the disordered region of E3s undergoes induced folding (or mutual induced folding) in the presence of the partner. In
conclusion, our data highlights the primary role of structural disorder in the functions of E3 ligases that manifests itself in
the substrate/adaptor binding functions as well as the mechanism of ubiquitin transfer by long-range conformational
transitions.
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Introduction
Proper functioning of a eukaryotic cell rests on a fine balance
between the synthesis and degradation of the thousands of its
proteins, i.e. proteostasis [1]. A major guardian of proteostasis is
the protein quality control (PQC) system, which ensures folding of
proteins to their native structure and their degradation if they
become superfluous or irreparably misfolded. Folding is assisted by
molecular chaperones [2], whereas degradation is orchestrated by
the ubiquitin-proteasome system (UPS), which tags misfolded
proteins or proteins, the action of which needs to be terminated,
with a covalently attached polyubiquitin chain for degradation by
the 26S proteasome. Ubiquitination also has degradation-inde-
pendent regulatory roles, because the attachment of a single
ubiquitin moiety (mono-ubiquitination), multiple ubiquitin moie-
ties (multi-ubiquitination) and even polyubiquitination through
different chain topologies (linking through Lysine63, for example),
modulate, rather than terminate, the action of proteins in diverse
cellular processes, such as transcription, endocytosis and cell-death
[3,4].
Ubiquitin is an extremely conserved protein of 76 amino acids,
usually attached to a Lysine residue of the target protein via its C-
terminal carboxyl group through an isopeptide bond. Ubiquitin
itself has seven Lys residues, which enable complex chain
extensions with distinct functional outcomes. Attachment of
ubiquitin is carried out by a series of proteins having ubiquitin
activating (E1), ubiquitin conjugating (E2) and ubiquitin ligase (E3)
activities. Structural and functional interplay of these enzymes and
their accessory proteins is crucial in controlling the activation and
transfer of ubiquitin to target proteins [5]. The system of
ubiquitination is built as a pyramid, reflecting the increasing
functional complexity leading from ubiquitin to the degradome/
ubiquitinome within the proteome.
Two E1s identified in the human genome are responsible for the
chemical activation of ubiquitin. So far, more than 30 E2s have
been identified: most of them contain a highly conserved ubiquitin
conjugation (UBC) domain [4,6] that forms a covalent interme-
diate with ubiquitin via its catalytic Cys residue. Most diverse is the
family of E3 proteins, which bring together ubiquitin-charged E2
(E2,Ub) and the substrate protein; they bind to their substrate
either directly or through adaptor/substrate recognition proteins
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[7–9]. The E3 family is commensurable in functional complexity
with the kinome [10]: based on functional and sequence criteria,
617 E3s have been suggested to exist in the human genome [11].
E3s are classified into two basic types: HECT (homologous to E6-
AP carboxyl terminus) E3s form an intermediate thioester bond
with ubiquitin [7], whereas RING (really interesting new gene),
and the related U-box E3s do not [8,9]; rather they bind both to
E2,Ub and the substrate to assist the transfer of the ubiquitin
moiety. In single-subunit E3s (ssE3s) such as single RING-finger
(sRF), U-box and HECT E3s, the E3 binds E2,Ub and the
substrate simultaneously, and requires no accessory protein for
action (although they are not necessarily monomeric in their active
state). On the contrary, multi-subunit E3s (msE3s, also termed
cullin-RING ligases, CRLs) form complexes in which E2,Ub
binding by multi RING-finger (mRF) and substrate binding by
adaptor/substrate recognition (such as APC (anaphase promoting
complex), ADAP (adaptor), VHL (Von Hippel-Lindau disease
tumor suppressor), DCAF (DDB1 and CUL4 associated factor),
BTB (Broad Complex/Tramtrack/Bric-a-Brac), F-box and SOCS
(suppressor of cytokine signaling)) subunits are separated and
connected by scaffolding cullin (CUL) proteins. The best studied
msE3 complex is SCF (Skp1-cullin-F-box), which belongs to the
CRL family [9,12].
Overall, the UPS system is a very complicated and highly
regulated network of proteins that can distinguish between folded
and misfolded states of its substrates far exceeding its components
in number. To address and possibly resolve the underlying
contradiction between coverage of the entire ubiquitinated
complement of the proteome (degradome, ubiquitinome) and
specificity for certain cellular situations and/or structural states, we
decided to look for intrinsic structural disorder in the E3 proteins
of the ubiquitin system and decipher the role(s) that intrinsic
protein flexibility and disorder may play in the ubiquitination
pathway. Many proteins or regions of proteins (intrinsically
disordered proteins/regions, IDPs/IDRs) exist and function
without a well-defined structural state, which provides distinct
functional advantages [13–15]. Structural disorder is increased in
proteins playing signalling and/or regulatory roles, in which it may
either enable flexible connection between binding elements
(entropic chain function) or is directly involved in molecular
recognition, harbouring short binding motifs or domains [16,17].
In these functions, structural disorder provides many advantages,
such as separation of specificity and binding strength, increased
speed of interaction, adaptability in binding, binding promiscuity/
moonlighting [18], and regulation by post-translational modifica-
tions [13–15]; these are all relevant for the functional challenges of
the UPS system. A few isolated observations have previously
shown evidence of structural disorder in members of the
ubiquitination pathway (e.g. MDM2 [19] and BRCA1 [20]),
and pinpointed the direct involvement of structural disorder of the
substrate (e.g. Sic1 [21]) or the E3 itself (e.g. San1 [22]) in
substrate recognition. In this work we establish a near-exhaustive
database of human components of the E1-E2-E3 system obtained
from both the KEGG BRITE server and perusal of the literature,
and show - by systematic bioinformatics analysis - an elevated level
and extended use of disordered regions/domains in this system.
We show that structural disorder of E3s is often involved in
substrate/partner recognition, and we also include a detailed case
study on the human E3 ligase c-CBL to demonstrate the
mechanism by which highly flexible regions (that are also
predicted to be disordered) facilitate transfer of the ubiquitin
moiety.
Results
Dataset of the human ubiquitination system
We assembled a comprehensive dataset of proteins involved in
the human ubiquitination system from data available in the
literature [11] and in the KEGG BRITE database [23–25]. Our
carefully curated database contains 2 E1, 29 E2 and 563 E3
enzymes (Tables S1, S2, S3 and Table 1); according to our
knowledge this is the first comprehensive, manually curated
collection of all experimentally validated members of the human
ubiquitination system. The workflow of data collection, filtering
and merging is detailed in Methods (see also Figure S1). We
adopted the classification of E3 proteins (Table 1, Figure 1) from
the literature [11].
E3 proteins are able to transfer ubiquitin directly to their target
protein by binding E2,Ub and substrate simultaneously (ssE3s:
HECT, RING-finger and U-box); others assemble into complexes
(msE3s), in which E2,Ub bound by a multi RING-finger protein
(mRFs: ANAPC11, RBX1, and RNF7) is connected to adaptor/
substrate recognition subunits (ADAP, APC, VHL, DCAF, BTB,
F-box and SOCS) via a scaffold protein cullin (CUL). Our final
dataset contained 302 ssE3s and 261 msE3s.
Disorder content of E3 ubiquitin ligases
First, we predicted intrinsic protein disorder with IUPred for the
E1, E2 and E3 proteins in our database and compared their
overall disorder content (Table 1). We observed an increase in
predicted disorder with E1s having the lowest, and E3s having the
highest levels (E1,E2,E3). The statistics were re-calculated using
two other disorder predictors (VSL2 [26] and FoldIndex [27]) and
the trend remained unchanged (Table S4). E3s were the most
disordered in all the distinct measures we calculated (i.e., average
number and percentage of disordered residues, number of mostly
disordered proteins and the number of proteins with long
disordered regions). The difference between the families is most
conspicuous in the ratio of mostly disordered proteins (those with
greater than 50% predicted disordered residues): there is no such
protein among E1 and E2 classes, whereas there are 48 in E3s.
This distribution reflects the increasing complexity in ubiquitina-
tion, also apparent in the number of proteins involved (E1: 2, E2:
29, E3: 563) and the number of their interacting partners. Given
that the mean length of E3s is shorter than E1s, the increased
disorder seen in E3s is even more significant in terms of their mean
number of disordered residues (E1: 63.0, E2: 81.4, E3: 146.7;
Mann-Whitney U-test (see Methods) p-value E2 vs E3: 0.016).
To unveil specific function-related properties we compared
disorder between different E3 subcategories (Table 1). In the
single-subunit subclass, RING (sRF) and HECT proteins have
higher mean disorder content than U-box proteins. About 60% of
sRF and 77% of HECT proteins have at least one long ($30
residues) disordered region, and, given their extreme length (1720
residues), HECT proteins excel in the total number of disordered
residues. In fact, HECTs are huge proteins consisting of many
long disordered segments intermixed with ordered domains [7].
The overall picture that emerges is that ssE3s constitute a rather
homogeneous class of long and significantly disordered (with a
mean around 22%) proteins.
On the contrary, msE3s (mRFs and the accessory proteins) are
extremely varied both in terms of length and disorder, reflecting
their functional specialization. mRF E3s are the shortest,
consisting of a single RING-finger domain and they are also the
least disordered among the E3 families (,1% predicted disorder).
Second to mRFs are the cullins (CUL: 6.0%), in accord with their
role as rigid scaffolds in the assembly of msE3 complexes. In
Structural Disorder in Ubiquitination
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contrast, the proteins involved in substrate binding (adaptors and
substrate recognition subunits) have disorder levels approaching
that of ssE3s (8–25%). This observed difference in the disorder
levels of substrate binding vs. scaffolding regions is also clearly
noticeable within the ssE3 and mRF families, where the two
different functionalities (E2-binding and substrate/adaptor bind-
ing) are combined within the same polypeptide chain. Using
domain definitions from UniProt [28] and the disorder scores from
the whole-protein predictions, we calculated the average disorder
separately for the E2 binding domains (RING/HECT/U-box) of
ssE3s and for the remaining (non-E2-binding) regions (where the
substrate/adaptor binding functions are localized), discarding only
transmembrane segments from the latter (Table 2). In all families
(HECT, sRF, mRF) except for the U-box, the E2 binding regions
are almost entirely structured (avg. disorder 1%), whereas the
disorder is concentrated in the non-E2 binding regions (24.6%)
(p,2.2E-16). The apparently contradictory result for the U-box
sub-family may be due to the paucity of data (6 members) or may
reflect an underlying functional difference with the other ssE3 sub-
families. A possible explanation could be the fact that the U-box
domain, unlike classical RING-domains, does not contain the
hallmark zinc-coordinating residues that stabilize the cross-brace
structure of the RING. The U-box scaffold is stabilized by salt
bridge and hydrogen bonding interactions mediated by strongly
conserved charged and polar residues [29]. The significantly
higher disorder predicted for the U-box (compared to the RING-
domains) may stem from the fact that classical predictors often
assign higher disorder values to charged and polar residues.
For a large majority of E3s (464/563) the ratio of disordered
residues is between 0% and 40% (Figure 2A) but there are also
several (48) which are mostly disordered (.50%). The majority of
the latter are found among ssE3s and in the BTB family of
adaptors, both of which actually combine adaptor and substrate
recognition functions in a single polypeptide chain [9,12]. At the
other extreme, for 74 E3 proteins (sRF: 26, HECT: 1, msRF: 2,
CUL: 1, ADAP: 1, BTB: 15, DCAF: 1, F-box: 18, SOCS: 6 and
VHL: 3) the ratio of disordered residues is close to 0. Thus, the
distribution of structural disorder of E3s shows an excess of
Figure 1. Predicted disorder of the main classes of human E3 ubiquitin ligases. We used the IUPred disorder prediction method for
predicting structural disorder in 563 human E3 ligases, and calculated the average percent of disordered residues for proteins in the different sub-
classes. The functional classification tree for the E3 family is shown above the bars. The specific functional characteristics for each main branch are
indicated in boxes, such as interaction with E2 enzyme and/or with the substrate (‘S’), transient covalent binding to ubiquitin (‘covalent’), or
functioning as a scaffold or adaptor/substrate recognition subunit in msE3s.
doi:10.1371/journal.pone.0065443.g001
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proteins with very low (0–5%) and also very high (40–100%)
disorder, which is reminiscent of the power-law (scale-free)
distribution of disorder in the entire proteome [30]. Such a
distribution most likely indicates the functional importance of this
feature. Figure 2A also includes a comparison with the distribution
of predicted disorder for the human proteome (14180 sequences at
30% sequence identity). However, we did not find any statistically
significant difference between the observed disorder distribution
for the E3 sample and the human proteome (p.0.01). Since in our
study we focus on the role of disordered regions, we repeated the
analyses in Figure 2A considering only the fraction of protein
residues occurring in long disordered regions (LDRs). The results
are shown in Figure S2A. For 147/563 and 35/563 E3s,
respectively, more than 25 and 50% of their residues are located
within LDRs. We also focussed on the abundance of LDRs
(defined as contiguous stretches of 30 or more predicted disordered
residues; intervening sections of 3 or less ‘ordered’ residues were
ignored). Figure S2B shows the distribution of LDRs in the E3
proteins and, for comparison, in the human proteome set. More
than 50% of E3s possess at least one LDR emphasizing the
functional importance of disorder in E3s; however, E3s are not
significantly different in terms of LDR occurrence compared to the
human proteome (p.0.01).
Although the E3 family does not differ markedly in overall terms
compared with the human proteome (Figures 2A and S2);
nonetheless, quantitatively similar disorder in different protein
families might manifest itself in strikingly different functional and
mechanistic terms. Therefore, in this manuscript we illustrate and
characterize the manner in which structural disorder manifests
itself in ubiquitination pathways, and elucidate the specific
Table 1. Overall disorder content of ubiquitin associated enzymes.
Enzymes
Average
length
No. of
proteins
Average% of
disordered residues
Average no. of
disordered residues
No. of mostly
disordered E3s (.50%)
No. of E3s with long (.=30)
disordered regions
E1 1055 2 5.97 63 0 1
E2 413 29 17.74 81 0 13
Different human E3 ubiquitin ligase families
Ubox 706 6 17.55 124 0 4
Hect 1720 22 21.38 401 0 17
sRF 640 274 22.98 159 31 164
mRFa 102 3 0.62 1 0 0
Total 714 305 22.54 175 31 185
ADAP 383 4 20.58 30 0 0
APC 677 9 24.02 83 2 6
CULa 790 6 6.01 49 0 1
VHLa 587 6 7.99 22 0 1
DCAF 792 22 23.73 232 1 16
BTB 624 105 19.41 133 10 60
F-box 563 71 14.62 101 3 33
SOCSa 389 35 12.10 88 1 11
Total 591 258 17.07 114 17 128
All E3s 657 563 20.03 146 48 313
sRF, HECT and U-box families belong to the single subunit subclass, mRF is the only family of the multi subunit subclass, and all the other families are E3 adaptor
proteins.
aThese categories of E3 proteins have significantly lower average% of disordered residues as compared to the E2 family. Mann-Whitney U-tests were used for the
statistical significance testing.
doi:10.1371/journal.pone.0065443.t001
Table 2. Disorder for E2-binding and non-E2-binding regions in E3 ligases.
E3 Family Avg disorder content E2-binding domaina (%) Avg disorder content non-E2-binding regionsb (%) P-valuec
Ubox 18.9 18.2 0.5314
Hect 1.2 28.8 1.509e-07
SRF 0.8 24.7 ,2.2e-16
MRF 0.0 1.1 0.2525
Total 1.3 24.6 ,2.2e-16
aE2-binding domains include RING/U-box/HECT domains as taken from UniProt.
bAll regions excluding RING/U-box/HECT domains and transmembrane segments based on UniProt.
cP-values calculated using the one-tailed Mann-Whitney U-test corresponding to the hypothesis that non-E2-binding domains are significantly more disordered than E2-
binding domains.
doi:10.1371/journal.pone.0065443.t002
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mechanisms by which E3 enzymes use structural disorder. The
importance of disorder is probably also manifested in its broad
correlation with protein length (Figure 2B), which suggests a
disproportionately large amount of disordered residues (regions) in
longer proteins. This underlying adaptive evolutionary drive is
probably also underscored by the outliers: the rigid scaffold cullins
[9,12], which have less, and sRF E3s, or adaptor/substrate
recognition subunits of msE3s (in particular DCAF, APC, and
ADAP), which have more disorder than expected by their length
(cf. Figure 1).
Interaction Classification
Due to the frequent involvement and manifold functional
advantages of disorder in protein-protein interactions, we next
asked if structural disorder in E3s is related to their interaction
properties. To this end, we positioned E3 enzymes within
intracellular interaction networks by merging two datasets of
interaction data: (i) a comprehensive set of experimentally
validated binary interactions between a large group of RING-
finger/U-box E3 proteins and UBC domain containing E2s [4],
and, (ii) interaction data in the STRING database for the 563 E3
ligases. We used the connectivity (‘k’) parameter to classify the E3s
into highly connected hubs (H, k$25), intermediately connected
proteins (ICP, 4#k#24), and, non-hubs (NH; k#3), based on the
number of their known interaction partners (Table 3 and Tables
S2 and S3). Interestingly, even by this high cutoff value (‘k’$25),
almost one fourth of E3s are hubs, which shows the central
position they occupy in the interactome. In agreement with earlier
general analyses of the relationship between disorder and
connectivity [31,32] hub E3 proteins have the highest mean
disorder content (22.9%), which is significantly greater than the
corresponding value for the non-hubs (18.4%) (p = 0.009)
(Figure 3). Intriguingly, this difference between hubs and non-
hubs is even more pronounced in E2-interacting E3s (HECT, U-
box, sRF and mRF) (Hubs, 28.02% vs. Non-hubs, 18.68%;
p = 0.0015) than in other E3s. A caveat here would be that, so far,
not all E3s have been extensively studied experimentally in the
context of identifying interaction partners. Therefore, the trends
observed here might actually become clearer when further
interaction data becomes available.
Even within single families there is a wide variation, with hubs
having much higher disorder than non-hubs (Table S5). Two
functional categories – cullins and mRFs – seem to defy this
relationship. Members of the mRF family – although two of them
are hubs and only one is an ICP – have very low disorder content
(0.93% and 0%, respectively for the two classes): they are very
short, well-conserved one-(RING)-domain proteins. They are not
in direct contact with their substrates and their various E2 and
cullin partners in the complexes tend to interact with them in
similar ways and using similar interaction sites. Similarly, the
cullins are conserved, folded proteins scaffolding multisubunit
(msE3) complexes. They do not recognize substrate proteins
either: together with mRFs they form a tight complex that serves
as the ‘‘catalytic center’’ of msE3s [12,33], with apparently
conventional enzyme-like structural attributes. Not surprisingly,
they have rather low disorder content even as hubs or ICPs (4.3%
and 14.57% respectively). It is of note that within this basic
structural layout, however, there are many possible ways of
assembly enabling probably hundreds of different CRL entities
[34], which explains their hub status within the interactome.
For proteins that interface the UPS with the proteome (ssE3s
and adaptor/substrate recognition subunits of msE3s) structural
disorder increases with ‘‘hubness’’ (Table S5). In the HECT, sRF,
VHL and SOCS families (which altogether account for 60% of the
total number of E3s in our database) there are proteins in all three
connectivity groups, and the mean disorder content strictly
increases from non-hubs through ICPs to hubs. While for the
HECT, sRF and SOCS families the mean disorder content for the
Figure 2. Distribution of the disorder content of E3s. Residue-level structural disorder was predicted for all 563 human E3 ligases by IUPred,
and the percent of disordered residues was calculated for each protein. A) The distribution of E3 proteins as a function of their disorder content. The
superposed line shows the disorder tendency for the human proteome (30% sequence redundancy). B) The average percent of disordered residues
as a function of the mean sequence length for different E3 families.
doi:10.1371/journal.pone.0065443.g002
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hub group ranges between 25–30%, for the VHL family is even
higher (.40%). Among the VHL family, only pVHL is a hub by
our classification criteria; although only 213 residues long, it has
57 high-confidence interaction partners. In good agreement with
its high connectivity, 42% of its residues are disordered. In the
ADAP and APC adaptor families all proteins are hubs (mean
disorder of 20.6% and 24.02%, respectively). The ADAP, DCAF
and F-box family proteins play an adaptor role in the complexes
formed by the RBX1 and the RNF7 (RBX2) mRFs, maintaining a
bridge between cullin and the actual substrate recognition subunit.
Although all these adaptor families contain proteins that are
classified into hubs, ICPs and non-hubs, their mean disorder does
not always increase as a function of the number of interaction
partners. A possible explanation might be the low number of
interactions identified thus far, as exemplified by the BTB and F-
box families, where a large majority of members are without any
known interaction partners, despite their role as an integral part of
msE3 complexes (Table S5).
Structural disorder and E3 function: folding transitions in
E3s
Elevated disorder in hub E3s suggests that E3 structural
disorder is involved in protein-protein interactions. Often,
disordered proteins/regions undergo folding transition upon
binding to their partner (induced folding or disorder-to-order
transition [35]). To provide concrete evidence that this occurs, we
collected 21 non-redundant structures from the PDB in which a
human E3 ligase is bound to another human interaction partner.
These cases fall into three distinct categories (Table S6): 1) E3
interacting with a UBC domain containing E2 (interaction
typically mediated by RING and UBC domains), 2) E3 interacting
with (an)other E3 (interaction typically mediated by the RING
domains of both proteins), and 3) E3 interacting with proteins
other than E2s/E3s: i.e., cofactor, substrate or other miscellaneous
partners (interaction mediated by regions other than the RING/
U-box/HECT domains). Because structural disorder is potentially
involved in this latter category (Table 2), we further analyzed and
sub-classified them into four types according to the structural
characteristics of the protein segments involved in binding from
both partners (Figure 4 and Figure 5): i) ssE3s interacting with
their partner via ordered segments of both, ii) induced folding,
when the interaction is mediated by a disordered binding region of
ssE3 that becomes ordered in the complex, iii) induced folding,
when the interaction is mediated by a folded domain of ssE3s and
a disordered segment of the partner, and iv) cofolding or mutual
synergistic folding [36], when both interacting protein segments
are disordered in the unbound state. We outline and analyze the
biological functioning of those complexes in which induced folding
of a disordered segment takes part in the interaction.
The induced folding of disordered E3 regions is exemplified by
CBL-B binding to the SH3 domain of the cofactor CD2AP
(Figure 4A) [37,38]. The same region of CBL-B also binds to the
SH3 domain of SH3K1 [39] (Figure 4B), demonstrating the
structural adaptability inherent in disordered proteins. The
interaction between a disordered segment of the MDM2 ligase
and the Math domain of USP7, which contributes to regulating
the p53 pathway, is also a case of induced folding of an E3
(Figure 4C). Yet another example of such an interaction is
observed between the disordered segment of AMFR2 and the
CDC48_N domain of TERA (Figure 4D) [40]. Interestingly, all
these interactions that rely on induced folding of E3s occur in
complexes with cofactors (CD2AP, UBP7, SH3K1 and TERA)
and not with other E1/E2/E3 enzymes or substrates.
Focusing on E3-substrate complexes, the cases we found in the
PDB showed that different types of interactions might occur
(Figure 5). In two cases, co-folding (mutual folding, synergistic
folding) occurs, when both partners are disordered prior to binding
to each other. The disordered region of the E3 SMURF1 interacts
with receptor-regulated SMADs (SMA and mothers against
Figure 3. Structural disorder of E3 ligases as a function of their
connectivity in the interactome. Disorder content for the three
connectivity groups of human E3s (hub: k$25, ICP: 4#k#24, non-hub:
k#3). Green circles represent individual proteins. The bottom and top
borders of the boxes represent the 25% and 75% of the data while the
bottom and top whiskers indicate 10% and 90% of the data,
respectively. The bold line indicates median value.
doi:10.1371/journal.pone.0065443.g003
Table 3. Disorder content of E3s and their classification based on their connectivity.
Based on all partners
No. of E3s Avg. length Avg.% of disordered residues Avg. no. of interaction partners
HUB 123 621.31 22.9 62.93
ICP 201 733.48 20.27 9.86
Non-HUB 239 612.29 18.36 1
HUBs are significantly more disordered than Non-HUBs: p-value = 0.009 (22.9 vs 18.36).
doi:10.1371/journal.pone.0065443.t003
Structural Disorder in Ubiquitination
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Figure 4. Induced folding of human E3 ligases in interactions with their partner molecules. PDB structures are presented in which a
disordered segment of a human E3 ubiquitin ligase binds to the folded domain of a human partner protein (neither an E1/E2/E3 enzyme nor a
substrate for the given E3). A) Interaction between E3 ligase CBL-B (CBLB) and CD2-associated protein (CD2AP; PDB 2J6F). B) Interaction between E3
ligase CBL-B (CBLB) and SH3K1 (SH3 domain-containing kinase-binding protein 1; PDB 2BZ8). C) Interaction between E3 ligase MDM2 and UBP7
(Ubiquitin carboxyl-terminal hydrolase 7, also USP7; PDB 2FOP). D) Interaction between E3 ligase AMFR2 and TERA (Transitional endoplasmic
reticulum ATPase, also VCP; PDB 3TIW). On all four panels the domain maps for the whole chain of both interaction partners are also shown, next to
Structural Disorder in Ubiquitination
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e65443
decapentaplegic homolog, Figure 5A) to trigger their ubiquitina-
tion and degradation specifically in the BMP (bone morphogenetic
protein) pathway [41]. Co-folding is also apparent between the
disordered segment of the E3 RING2 and RYBP (RING1 and
YY1-binding protein, Figure 5B), which results in RYBP mono-
ubiquitination [42]. The inherent adaptability of IDPs is also
demonstrated by the somewhat different molecular logic of E3
MDM2 (murine double minute 2) binding to its premium
the PDB structure: the upper map is for the E3 ligase, the bottom one is for the partner. In the structures, the disordered E3 chains are represented as
purple cartoon while the partner molecule is rendered in surface representation. The domain maps show the lengths and names of the proteins and
their domains. The regions predicted to be disordered by IUPred are marked in purple, the ordered segments are in white; the regions present in the
PDB structures are delimited by asterisks.
doi:10.1371/journal.pone.0065443.g004
Figure 5. Induced folding in the interaction of E3 ligases and their substrates. Three PDB structures are presented in which induced folding
or mutual induced folding (cofolding, synergistic folding) occurs upon interaction of a human E3 ligase with its substrate. A) Interaction between E3
ligase SMURF1 and its substrate SMAD1 (SMA and mothers against decapentaplegic homolog 1; PDB 2LAZ) is a case of co-folding of two disordered
regions. B) Interaction between E3 ligase RING2 and RYBP (RING1 and YY1-binding protein; PDB 3IXS) is also an example of co-folding. C) Interaction
between E3 ligase MDM2 and P53 (P53 tumor suppressor protein, also TP53; PDB 1YCR), here the substrate undergoes induced folding upon binding
to the folded SWIB domain of MDM2. On all three panels PDB structures and domain maps of the two proteins (E3 on top) are shown. On the domain
maps, the names of domains, their positions and total length of the protein are indicated. The regions are color coded according to their IUPred
disorder status: regions predicted to be disordered are in purple, ordered segments are in light grey. The regions present in the PDB structures are
delimited by asterisks. In the PDB structures the disordered segments of partners are shown as purple cartoon whereas the E3 ligase is rendered in
surface representation; disordered regions (mapped from disorder predictions on the unbound form) being light grey, and ordered regions white.
doi:10.1371/journal.pone.0065443.g005
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substrate, p53. As noted above, a disordered segment of MDM2 is
involved in binding the co-regulatory USP7 (UBP7_Human,
Figure 4C). Here, the disordered segment of p53 binds the folded
SWIB domain of MDM2 (Figure 5C). This interaction enhances
the AKT-mediated phosphorylation of MDM2 increasing its
interaction with p-300 for MDM2-mediated ubiquitination and
degradation of p53 [43,44]. Although these few examples do not
enable generalizations, it is at least interesting that in all three cases
(p53, RYBP and SMAD1) a disordered region of the substrate is
involved in mediating the interaction.
When analyzing the types of secondary structure that the
disordered regions (IDRs) adopt in their bound states, we find that
out of the four examples of E3-cofactor binding (Figure 4), the
AMFR2-TERA interaction alone shows evidence of formation of
an a-helical segment (Figure 4D). The other three are no longer
disordered, but adopt an extended, coil-like conformation. In the
three representative examples of E3-substrate interactions
(Figure 5), two of the three cases result in the IDR folding into
regular secondary structures (a b-hairpin and a partial a-helix). To
understand ‘‘induced folding’’ occurring in these examples from
the E3 family, we used the results from a large set of ‘Molecular
Recognition Features’ (MoRFs) [45] that characterize those
regions of disordered proteins that undergo disorder-to-order
transitions upon binding to their partners. Based on the structures
adopted after binding, three basic types were described: a-MoRFs,
b-MoRFs, and irregular. Nearly 50% of the MoRF dataset
consisted of irregular secondary structures. Another previous study
had also commented upon the high incidence of coil structures in
the bound form of 24 IDPs [46]. Several specific examples of
disordered (extended) loop regions in monomeric proteins
becoming ‘fixed’ in the interface regions of the complex have also
been discussed in the context of disorder-to-order transitions
during protein complex formation [47]. Further, this phenomenon
may be more universal and not restricted to IDPs; the common
occurrence of non-regular secondary structural elements in
binding interfaces has also been observed in the case of globular
protein-protein interactions, and, in transient hetero-complexes in
particular [48].
Structural disorder and E3 function: the role of inter-
domain linkers
To comprehend the linker properties that have evolved in ssE3s,
we analysed all sRF and U-box-type ssE3s in our dataset in terms
of their UniProt domain assignments. Linkers that connect
adjacent E2-recognition and substrate-recognition domains are
functionally important for E3 ligase catalytic activity and ubiquitin
transfer (a case study is described in detail in the following section).
HECT ssE3 family members were not included as these proteins
use a very different mechanism for catalysis (as commented upon
in the Introduction). For almost one third (91/280) of sRF/U-box
E3s, UniProt showed only the presence of a single RING/U-box
domain, which means that the substrate recognition is most
probably carried out by the surrounding, non-domain regions.
The average disorder content of these non-domain regions was
,30%, implying that, at least in certain cases, disordered regions
could be directly involved in substrate recognition. The next
scenario (for which a linker region can be clearly identified)
involves sRF and U-box ssE3s for which at least one of their
domains were previously described in the literature as being
capable of substrate recognition. We only considered linkers
spanning a RING/U-box domain (binding the E2 with the
activated Ub moiety) and an adjacent potential substrate-
recognition domain devoid of any intervening other domains or
trans-membrane spanning regions. We could identify 90 such
linkers in our dataset: an example is shown in Figure 6; see also
Figure 7 for a schematic representation). In these cases, the inter-
domain linker functions as a flexible hinge bringing these domains
into close spatial proximity, thereby facilitating the transfer of
ubiquitin from the E2 to the substrate. This dynamic inter-domain
motion (Figures 6 and 7) would also potentially account for the
processivity observed in ubiquitination and a relatively unrestrict-
ed spatial search for the correct ubiquitination site on the target
protein (thus enabling poly-ubiquitination, multiple mono-ubiqui-
tination, as well as a variety of other complex Ub-chain
extensions).
Linker regions between adjacent E2-binding (RING/U-box)
and substrate/adaptor-binding domains were identified. The
length distribution of these 90 linkers and their predicted disorder
are plotted in Figure S3. 67% (60/90) of the linkers are within 50
residues length, but there are a significant number with lengths
between 50–200 and larger than 200 residues (22% and 11%,
respectively) (Figure S3A). The longest linker observed in this set
was 1576 residues, belonging to the BRCA1 E3 ligase. We also
calculated the average disorder score for each linker (Figure S3B):
the distribution shows that 37% (33/90) of the linkers have an
average disorder score of less than 0.20. However, most of the
linkers (63%) have greater than 0.20 average disorder score. Of
interest, ,24% of the linkers have more than 0.40 average
disorder score. However, the correlation between linker length and
average linker disorder score is poor (correlation coefficient 0.34),
indicating that a complex interplay between linker length and
disorder may be employed by this family to manage the intricacies
of ubiquitination. Moreover, specific E3s could have specific
tendencies towards specific chain extension reactions, and this
would probably manifest in the properties of the linker; this would
also depend on the nature (shape, size and surface properties) of
the substrate(s) that the cognate E3 has evolved to recognize and
ubiquitinate.
Case study: large-scale conformational dynamics and E3
ligase activity in human CBL
To demonstrate the potential mechanistic role of highly flexible,
disordered linkers in E3 activity, we selected from the PDB the
structure of a single-subunit E3 (human Cbl), bound to its cognate
E2 and a peptide derived from its substrate ZAP-70 (PDBid:
4A4C) [49]. Cbls are RING ubiquitin ligases that attenuate
receptor tyrosine kinase (RTK) signal transduction. The structure
of the E3 Cbl consists of an N-terminal tyrosine kinase binding
(TKB) domain and a C-terminal RING domain connected by a
linker helix region (LHR) (Figure 6A). Cbl ubiquitination activity is
stimulated by phosphorylation of a LHR tyrosine residue. We used
IUPred and FoldIndex to predict disorder in the E3 sequence. The
disorder profiles showed a distinctive peak in the linker region
(Figures 6B,C) suggesting that the linker is flexible and therefore
might be critical for juxtaposing the E2 and the substrate-binding
TKB domains during ubiquitin transfer. The linker in this
particular E3 is not an IDR, unlike disordered linkers that may
be present in other E3 ligases (Figure S3B). The disorder profile
shows a distinctive peak in the LHR (although it does not cross the
threshold for an appreciable stretch of residues), and the following
analyses also shows this linker to be the most flexible part of the
structure, and functionally crucial for the enzymatic activity. The
crystal structure of the unbound Cbl (PDBid 2Y1M), however, has
missing electron density for the first few residues of the linker,
showing that indeed the linker may be at least partially disordered.
The profile also shows a second peak in the region 130–145, and
this corresponds to an extended surface loop that is part of the
substrate-binding domain. When we analyzed the crystal B-
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factors, again we saw a broad peak in the region encompassing the
linker helix (Figure 6D). The domain organization of the E3
molecule and its association with the E2 and the substrate clearly
demands that a conformational change altering the relative
orientation of the two lobes (TKBD and RING) is required to
allow the catalysis to take place, because the distance between the
E2 active site Cys residue and the substrate peptide observed in the
experimental structure is too large to permit effective ubiquitin
Figure 6. Structural organization and molecular dynamics analysis of an E2-E3-substrate complex. Structural and molecular dynamics
analysis of the complex (PDB code: 4A4C) between human CBL, ubiquitin-conjugating enzyme E2, and a peptide derived from the CBL substrate ZAP-
70. (A) Structural organization of CBL, as seen in the crystal structure. The E3 molecule is in blue, E2 in dark grey and the ZAP-70 substrate peptide is
in red. The predicted disorder profiles of the CBL sequence present in the crystal structure using (B) IUPred, and (C) FoldIndex, respectively. Vertical
lines represent the linker helix region (CYS353-CYS381). In the IUPred plot, peaks represent the predicted disordered region(s), whereas in FoldIndex
the negative values correspond to unfolded/disordered regions. The disorder calculations were run for the entire CBL sequence (UniProtKB: P22681),
but the figure only shows the peptide segment (PRO48 – ASP435) present in the crystal structure. (D) Sequence of CBL with blue color indicating
regions with high crystal B-factors (.100A˚2). (E) RMSF plot from the 50ns MD simulation. (F) Distance between the center-of-masses of the substrate-
binding TKB domain of CBL and the E2 as a time-series plot from the MD simulation. (G) Distance between the E2 catalytic CYS and the N-terminal
SER of the ZAP-70 peptide. (H) Two orientations (‘‘open’’ and ‘‘closed’’ forms) of the E2-E3-substrate peptide complex obtained from the NM
simulation. They correspond to two extreme configurations (along the lowest frequency normal mode), showing the bending around the linker helix
region that acts as a hinge/lever. The ‘‘open’’ configuration is colored dark grey, and the ‘‘closed’’ configuration is colored blue (E3), and orange (E2).
The catalytic CYS85 and the substrate peptide are shown in spacefill representation. CYS85 are shown for both the open and closed forms of the
structure, whereas the substrate peptide is shown only for the closed form (for clarity). The TKB domains of the two different configurations are
structurally superposed using the C-alpha atoms. The TKBD is aligned with very low RMSD, whereas the RING-domain and the E2 have moved
significantly in the two conformations (in the direction pointed by the curved arrow).
doi:10.1371/journal.pone.0065443.g006
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transfer. In an attempt to understand and characterize the degree
and precise nature of the required conformational change, we
applied both normal modes and molecular dynamics simulations
to demonstrate the intra-molecular ‘‘diffusion’’ of the E2-binding
RING domain and the substrate binding TKB domain towards
each other, thereby bringing the ubiquitin and substrate in closer
proximity.
A 50 ns molecular dynamics trajectory for the complex was run
and analyzed for evidence of linker flexibility. First, we observed
high RMSF values around CYS353:CYS381 (the linker helix
region) indicating that this region is the most flexible in the entire
E3 structure (Figure 6E). During the simulation, the distance
between the centers-of-mass of the substrate-binding TKB domain
and the E2 fluctuate and at certain times come significantly closer
(compared to the distance in the starting crystal structure). We
measured the distance between the center-of-masses of the TKBD
and the E2 as a function of simulation time, and the plot shows an
approximately 1 nm (10A˚) fluctuation in the distance (Figure 6F).
A similar significant decrease is noticed in the distance between the
center-of-masses of the TKBD and the RING-domain of the E3
(that binds directly to the E2) (plot not shown). We also computed
the time-series plot of the linear distance between the E2 catalytic
CYS and the N-terminal end residue (SER4) of the ZAP-70
substrate peptide (Figure 6G). In the 4A4C crystal structure the E2
catalytic CYS and the ZAP-70 peptide are separated by
approximately 28A˚. This is a crude approximation for the distance
between the catalytic CYS on the E2 and the target LYS residue of
the substrate that will be ubiquitinated (not present in the crystal
structure); nevertheless the plot shows a dynamic fluctuation in the
distance. We note that this linear distance varies between ,2–
4 nm (20–40A˚) during the course of the simulation. The minimum
distance obtained from the trajectory (,1.9 nm, or 19A˚) lowers
the distance observed in the crystal structure to a much more
reasonable value for the ubiquitin transfer reaction. Taken
together, the MD results clearly indicate an inter-domain closure
motion occurring in the E3, with the linker helix region acting as a
flexible (also predicted to be disordered using IUPred) hinge.
In order to analyze the long-term dynamical properties of the
system, we also examined the normal modes of the complex using
the ElNe´mo webserver. The five lowest frequency modes for the
complex were calculated and the motions along each of these
specific modes can be visualized as movies showing the structural
rearrangements suggested by the Coarse Grained-NMA (Supple-
mentary Zip Files S1). The first and fourth lowest frequency modes
in particular appear to enable a long-range conformational change
that significantly reduces the linear distance between the E2
catalytic Cys (colored yellow in the supplementary movies) and the
substrate peptide (red). The linker helix region (LHR) appears
highly flexible and behaves as a swinging lever arm. Thus the
normal mode motions clearly identify it as a hinge/lever that
enables the relative movement of the E3-RING and the TKBD
domains, and is thus responsible for bringing the two domains
close to each other. Figure 6H presents the extreme ‘‘open’’ and
‘‘closed’’ forms of the complex taken from the displacement along
the lowest frequency normal mode. These low frequency motions
readily support the high catalytic efficiency of CBL. To identify
the hinge residues, we used HingeProt [50] with the 4A4C PDB
structure: two of the three hinge residues in the lowest frequency
Figure 7. Structural disorder enables intramolecular diffusion in E3 action. A simplified scheme of the linker (entropic chain) function of
disordered regions in E3 ligases (for molecular recognition function, see text and Figures 4 and 5). Several ligases of the ssE3 family have a substrate-
binding domain (SBD, can also be a disordered motif) and an E2-binding domain (shown as RING here, can be also a U-box or HECT domain)
separated by a disordered linker region (dashed line). Due to the conformational freedom of the disordered linker, the bound substrate (S) and
ubiquitin-charged E2 (E2,Ub, ubiquitin shown in red) can diffuse toward and away from each other, without dissociating from the E3. This
‘‘intramolecular diffusion’’ mechanism enables proximity of substrate and E2,Ub for ubiquitin transfer and also subsequent replacement of E2 with
E2,Ub in a more open conformation, i.e. (re)charging of the ligase. In principle, the flexibility of the linker enables the polyubiquitiniation or multiple
monoubiquitination of the substrate, which may explain processivity of the ligation reaction.
doi:10.1371/journal.pone.0065443.g007
Structural Disorder in Ubiquitination
PLOS ONE | www.plosone.org 11 May 2013 | Volume 8 | Issue 5 | e65443
mode are located in the LHR. Upon repeating the HingeProt
analysis using only the E3 ligase coordinates, we found that the
sole identified hinge residue in lowest mode 1, and one of the two
hinge residues in mode 2 are LHR residues. A comprehensive
analysis of such concerted, large-scale rearrangements involving
disordered or flexible regions in different types of E3 ligases is
currently under progress (Guharoy et al., unpublished results).
Discussion
The UPS is one of the most important elements of quality
control in the cell, maintaining proteostasis, a healthy balance of
functional proteins [1,2]. The system chemically activates ubiqui-
tin via ubiquitin activating (E1) enzymes, which is then transferred
to one of a few dozen ubiquitin conjugating (E2) enzymes. E2 with
its labile ubiquitin moiety (E2,Ub) is brought together with the
substrate by one of several hundred ubiquitin ligases (E3), which
interface the system with the entire proteome. Due to an
increasing complexity of the system from ubiquitin to the entire
degradome/ubiquitinome within the proteome, we expected an
increase in the level of structural disorder from E1 through E3
enzymes. In this study, we observe an overall high structural
disorder that increases from E1s to E3s. Although this correlation
does not prove involvement in function, there are many individual
observations and multiple lines of indirect evidence that substan-
tiate its role in E3s. Due to the extreme heterogeneity and
complexity of the system, it is difficult to draw general conclusions;
however certain unifying themes clearly appear.
In general, structural disorder is high in proteins having
signalling and regulatory roles [13–15], where it either provides
a flexible link between binding elements (entropic chain function)
or it is directly involved in molecular recognition via short binding
motifs or domains [16,17]. In these functions, structural disorder
provides many advantages through fine-tuning the kinetics and
thermodynamics of molecular recognition events. Based on these
premises, the observed elevated level of disorder in E3s is
compatible with its use in E3 ligases. Prior limited structural/
biophysical studies also demonstrated the abundance (e.g. in
MDM2 [19], and BRCA1 [20]), and functional involvement (e.g.
in San1 [22], and Sic1 [21]) of structural disorder in E3 action. In
case of MDM2, disordered binding motifs (regions 235–259 and
275–289) are involved in the interaction with the highly disordered
N-terminal region of Arf, where a mutual binding-induced folding
(co-folding) transition occurs, coupled with extensive b-strand
formation in both partners [19]. BRCA1 has a more than 1500
residues long disordered region (between domains RING and
BRCT; residues 103–1646) that mediates a plethora of different
interactions via short peptide motifs showing some secondary
structure tendency even prior to binding to the partner [20].
According to Foray et al. [51] BRCA1 acts as a major scaffold
protein in DNA damage response binding non-DNA associated
downstream phosphorylation targets (such as p53, c-Jun, Nbs1 and
Chk2) and enabling ATM or ATR to efficiently modify them.
A unique functional consequence of structural disorder is
manifested when two binding elements (motifs or domains)
separated by a disordered linker enable a relatively unrestricted
spatial search for distinct binding sites. The functional advantages
have been described in several well-studied systems, where the
linker enhances or even determines specificity [52], enables
processivity [53], increases binding strength [54], promotes
regulatory communication between distant sites [55,56], and
facilitates the search for distant partners by reaching out in space
[57,58]. In fact, flexibility – without explicitly mentioning
structural disorder - is very often mentioned in the E3 literature
to explain paradoxical observations, such as the huge gap between
the bound E2,Ub and substrate in CRL (msE3) ligases [8,9] and
processivity in polyubiquitination [5,59,60].
In principle, bound E2,Ub and substrate may be brought
together if the two binding regions are linked by a (long)
disordered linker region, which enables E3 to undergo large
conformational changes between extended and more compact
states. For example, this might be the case of MDM2, in which the
RING and SWIB domains are separated by 332 residues, and also
in BRCA1, in which the RING and BRCT domains are separated
by a predominantly disordered region comprising nearly 1500
residues [20]. This kind of mechanism manifests itself even in CRL
ligases, which, at first glance, appear as rather rigid complexes
[9,12] presenting a large separation (50–60A˚) between bound
E2,Ub and the Lys residue(s) to be modified on the substrate.
Whereas a mutation increasing the flexibility of cullin impairs E3
activity [61], it has been suggested that substrate-binding subunits
have a flexible inter-domain linker that serves as a hinge, around
which the two domains rotate relative to each other to properly
position the substrate for ubiquitin transfer [62]. This is also what
we demonstrate taking the case study of the single-subunit CBL-B
E3 ligase (Figure 6). It was also hypothesized that in the active state
of CRLs, E2,Ub is released from cullin and diffuses toward the
substrate. Although this ‘‘hit-and-run’’ mechanism [63] has been
criticized [33], it does illustrate clearly the functional opposition
between rigidity and flexibility in E3 operation, which may be
resolved by structural disorder. Further along this avenue, it was
observed that the covalent attachment of the ubiquitin-like
NEDD8 protein to cullin stimulates substrate ubiquitination by a
special mechanism: X-ray crystallography and SAXS experiments
demonstrate that the RING domain of Rbx1 is freed from cullin
upon covalent modification by NEDD8, remaining tethered to
cullin only by a short linker that can attain multiple conformations
[64]. The presence and operation of this dynamic linker is not far
from the idea of functionally important structural disorder
(‘‘fuzziness’’) in the bound state of proteins [65].
Our general premise is that structural disorder between the
substrate- and E2,Ub-binding regions of E3 ligases enables an
‘‘intramolecular diffusion’’ mechanism, in which bound E2,Ub
and substrate are relatively free to move toward and away from
each other (Figure 7). This mechanism enables ubiquitin transfer
and it would also shed light on yet another mystery of protein
ubiquitination, its processivity, which is in stark contrast with the
strict geometric restraints of an enzymatic reaction [60]. In quality
control, a polyubiquitin chain consisting of at least four subunits is
built up by the sequential conjugation of ubiquitin moieties, and,
even in regulatory monoubiquitination reactions very often several
ubiquitin moieties are attached onto the substrate at adjacent sites
(multi-ubiquitination). It was already suggested that structural
disorder of the substrate might provide the flexibility necessary to
bring adjacent substrate sites in proper orientation [59]. In our
model, structural disorder of the E3 itself may enable such
intramolecular diffusion, due to which several ubiquitin moieties
may be added without full dissociation of the bound substrate
(Figure 7). Normal mode simulations have proven effective in
representing large-amplitude conformational changes (for exam-
ple, domain and hinge-bending motions) in proteins [66]. Indeed,
it has been shown that for several systems, the lowest frequency
modes contribute the most to a conformational change. Although
care is required in interpreting the results of molecular simulations,
these are extremely relevant for formulating useful hypotheses. In
this analysis, we have used state of the art methodologies to gain
access to the dynamics of ubiquitin transfer and the role of flexible
linker regions in E3 activity. Much of our understanding of the
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regulation of RING E3s comes from structural and mechanistic
studies of multi-protein RING complexes such as cullin-RING
ligases (CRLs) [62]. Although both single-subunit and multi-
protein classes consist of about 300 members in the human
genome, the mechanisms of single-subunit RING E3 regulation
remain poorly understood. That is why we have selected the
example of human CBL to demonstrate the role of linker flexibility
and disorder in the mechanism of ubiquitination. Our results
produce a very realistic model that can account for the proposed
mechanism of Ub transfer and the manner in which the flexibility
of the E3 linker facilitates the functional motion (Figure 6).
Function abrogating (and therefore, disease-causing mutations) in
c-CBL also point to the importance of the disordered linker for
function. Tyr371 of the LHR in c-CBL has emerged as one of the
most frequently mutated residues found in people with myeloid
neoplasms [67].
The evidence is even more straightforward for the involvement
of structural disorder of E3 ligases (or their partners) in protein-
protein interactions. The examples collected from the PDB
(Figures 4 and 5) demonstrate that binding mediated by induced
folding occurs both with cofactors (CD2AP, UBP7, SH3K1 and
TERA) and substrates (p53, RYBP and SMAD1). From the
substrate side it has been reported that there is a small but
significant bias of ubiquitination sites (that lead to degradation for
mammalian proteins) to be enriched in disordered regions [68].
Further, the presence of long disordered regions (LDRs) has been
shown to be essential for proteasomal degradation in certain
studies, with these unstructured regions serving as the initiation
region for proteasomal proteolysis [69,70]. Indeed, the absence of
LDRs apparently increases the survival in case of Rad23, and
these requirements may reflect a general property of the
proteasome [71]. Structural evidence is also provided in many
cases that the binding of short disordered degradation motifs
(degrons) of E3 substrates occurs via folded protein-protein
interaction domains (e.g. WD40 beta propeller or leucine-rich
repeat (LRR)) of the substrate recognition subunits of CRLs [72–
75]. In an extreme case, targeting of yeast Cdk inhibitor Sic1
occurs by binding to the WD40 domain of the Cdc4 subunit of
SCFCdc4 through a ‘‘polyelectrostatic’’ interaction [21]. In this
largely disordered state, multiple short disordered degrons
cooperate in binding, which results in a largely disordered, fuzzy
[65] complex between the substrate and its cognate E3.
Although direct structural evidence is missing most of the time,
the role of structural disorder in molecular recognition also follows
from observations that the binding site falls within a region of E3
that lacks a folded domain. In the founding member of the HECT
family, E6-AP, both E6 viral adaptor protein and substrate p53 are
bound by a disordered region N-terminal to the HECT domain
[76]. The central, 1500-residue long disordered region in BRCA1
has been reported to serve as a scaffold for multiple protein
partners (e.g. p53, cMyc) [20]. Ubr1p, which is the E3 component
of the N-end rule pathway in yeast, depends largely on a basic
region for binding its E2 Ubc2p [77]. The C-terminal Pro-rich
and acidic regions of Cbl-C, which is also predicted as extensively
disordered, is known to be involved in substrate binding [78]. The
most intriguing case is San1, an yeast E3 ubiquitin ligase localized
in the nucleus, involved in quality control cellular mechanisms, but
with no defined human homologue. San1 can indeed distinguish
between the misfolded states of its substrates via intrinsically
disordered N- and C-terminal domains [22]. Within these
disordered regions, there are short conserved recognition ele-
ments, the plasticity of which enables them to transiently bind
differently shaped misfolded substrates. Besides E3s, often their
partners also use disordered segments for interaction. For
example, the E2 Cdc34 uses its long disordered C-terminal
domain to bind to SCF [79]. Structural disorder may also be
involved in the assembly of CRLs in an even more subtle way.
Although E3-E2 interactions are largely mediated by RING-UBC
binding, the disordered flanking regions of the UBC domain in
family 3 E2 enzymes contributes to the specificity toward E3
partners and also cognate Ub-like molecules [6].
Our comparative studies further provide such indirect evidence
for the role of structural disorder in protein-protein interactions in
E3 ligases. In the case of msE3s (CRLs), E2,Ub-, substrate-, and
possibly cofactor binding is associated with separate regions/
subunits of the complex, all of which are contained within a single
polypeptide chain in ssE3s. In agreement with data in the
literature [11], our calculations show that 223 out of 302 ssE3s
have only one folded protein-protein interaction domain (HECT,
RING or U-box), which mediates E2,Ub binding. Therefore,
their binding of additional factors and/or the substrate has to be
contributed by (disordered) regions outside the domain. The role
of structural disorder in molecular recognition also follows from
our interaction network analysis. Structural disorder is known to
be significantly higher in proteins of multiprotein complexes and
hub proteins with multiple interactions [31,32]. Similar signs are
apparent in the UPS system. First, E3 proteins are by far the most
disordered in the network, most likely due to having interaction
functions that are more complicated than either E1 or E2 proteins.
Second, ssE3s are invariably very disordered (in particular, their
substrate- and adaptor-binding regions) (Table 2), whereas
subunits of msE3s are much more diverse. msE3 subunits involved
in E2,Ub binding (mRFs) and scaffolding (cullins) are largely
ordered (Table 1), whereas subunits with adaptor/substrate
recognition functions (e.g. DCAF, BTB, F-box, SOCS…) are as
disordered as ssE3s, and often contain long disordered regions.
Third, our analysis of hubs based on analyzing the number of
interaction partners in the STRING database clearly shows that
hub E3 proteins are significantly more disordered than non-hubs
(p-value = 0.009) (Table 3).
Besides its prevalence in protein-protein interactions, structural
disorder is also abundant in proteins of signaling and regulatory
functions [13–15], because it enables regulatory communication
between remote segments of the protein [56], and also effective
regulatory post-translational modifications [16,80]. These func-
tional modalities also appear in the E3 family. Long-range
regulatory communication is apparent in Smurf-2, for example.
Smurf-2, a HECT E3 ligase, is kept quiescent by an intramolec-
ular interaction between its N-terminal C2 domain and C-
terminal HECT domain, the two domains being separated by a
340-residue, largely disordered stretch interspersed with short WW
domains [81]. It is activated by the adaptor Smad7, which
displaces the C2 domain by binding to HECT domain and
thereby makes it accessible for membrane binding and transloca-
tion from the nucleus to the cytoplasm. Regulation by post-
translational modifications has also been described in many cases:
for example, phosphorylation of a tyrosine in the linker region of
Cbl-C results in a more rapid turnover of bound E2 (UbcH5b)
leading to activation of E3 activity [82]. A further example is the
phosphorylation of MDM2 that relieves autoinhibition, and
thereby facilitates the productive interaction of p53 with its SWIB
domain [83,84]. The action of E3s is very often regulated by
phosphorylation, where either the E3s themselves undergo
modification [8], or their substrates are subject to regulation, for
example by the formation of an activated phosphodegron [21,73].
Two further pieces of evidence attest to the direct and causal
involvement of structural disorder in the functioning of E3 ligases.
First, the observed scale-free distribution of disorder in this family
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is a strong indication of this feature (Figure 2A). Scale-free
distribution has been observed in many biological networks, such
as the number of interaction partners in the interactome [85], and
has been interpreted as evidence that strong system-level selection
acts on this feature. This selection ensures a relative enrichment
for small and large number of occurrences, in comparison to a
random distribution, due to their special functional involvement.
Here we observe the same behaviour in case of E3s, which strongly
argues that their level of structural disorder is a feature subject to
strong evolutionary selection forces. An additional indirect
evidence for the importance of structural disorder in E3 ligases
comes from the location of (familial) missense mutations causing
disease. For example, about 10 out of 30 mutations in Parkin [8],
and 80 out of more than 100 in BRCA1 [20] occur in disordered
regions. Whereas the location or even the type of these mutations
reveals little about their exact role, their abundance makes it
unquestionable that the disordered regions in which they reside
make an essential contribution to the functioning of these E3
ligases.
Conclusion
We have presented in this work several parallel lines of evidence
for the use of structural disorder in the ubiquitination system.
Initially, we were intrigued to find scattered in the literature, hints
suggesting the existence and use of disorder in this system (as
detailed in Discussion). In the present study, in order to formalize
the role of disorder, we collect all currently available information
about the sequences, interactions and structural data for Ub-
enzymes, and then describe the occurrence and location of
disorder in the context of their sequences, structures and
interactions. We find that the E3 protein family exhibits
significantly higher disorder characteristics than the other mem-
bers. In the pyramidal setup of the Ub-system (where the E3s can
be seen to form the connecting bridge between the UPS and the
proteome), this unambiguously indicates that structural disorder
confers manifold functional advantages in E3 function. The E3/
substrate interface is also functionally the most complex, as it
entails recognition of many thousands of potential substrates by
approximately 600 human E3 ligases (meaning that a particular
E3 would be responsible for ubiquitinating multiple substrates). In
accordance with these requirements, we indeed observe that the
E3 system is critically dependent upon disorder features that
principally enable (i) multi-specificity partner (substrate) recogni-
tion, and, (ii) E3 catalytic function (ubiquitin transfer to substrate)
and its inherent processivity. The different types of evidence
presented in this work include bioinformatics predictions of
structural disorder, disorder in the context of structural data for
E3-substrate/cofactor/adaptor combinations, and molecular dy-
namics-based mechanisms of action of E3 ligases involving flexible
(and, sometimes, predicted disordered) linkers. These merge
together to present a comprehensive picture of the manner in
which structural disorder facilitates the mode of action of
ubiquitinating enzymes.
Methods
Downloading human E1, E2 and E3 data from the KEGG
BRITE database
Two well-annotated human E1 sequences were extracted from
the KEGG BRITE database [23–25] (Table S1). Of the 30–40
E2s predicted for the human genome [86], 35 known to be
involved in ubiquitination were obtained from the literature [4].
E2 sequences were also downloaded from the KEGG database: 33
sequences were obtained, but all these E2s were already present
within the literature set. In order to identify redundant sequences,
we ran the CD-HIT clustering algorithm with a threshold of 85%
sequence identity. 29 sequences (out of the 35) were kept following
this filter, by always retaining the best annotated one from the
clusters of highly similar sequences (Table S1).
We retrieved a total of 468 proteins from the KEGG BRITE
database that we grouped as ‘‘E3’’ components. Those included
HECT, RING, U-box (and RBR, within the RING group) E3s
together with their putative scaffolding, adaptor, substrate-
recognition, accessory and/or regulatory proteins (see Table S7).
This initial list of E3-components was screened to obtain a high-
quality and reliable dataset (several filtering criteria were applied).
In the first step, we removed four KEGG sequences with
ambiguous and uncertain annotations such as ‘‘acting like’’, ‘‘by
similarity’’, ‘‘potential’’, ‘‘probable’’ or ‘‘possible’’. Second, we
checked if there were multiple KEGG entries with identical gene
names: only one such instance was observed (KEGG HSAs 51130
and 100302652 had an identical UniProt gene name ‘ASB3’), and
only the ‘‘reviewed’’ (i.e., manually annotated in UniProt)
sequence (HSA: 51130) was retained out of the two [87]. Third,
one single-RING-finger (sRF, belonging to ssE3s) E3 (HSA:
390231) was found to be a pseudogene, and fourth, we identified
another candidate E3 (HSA: 652346) for which there was no
sequence information in the KEGG database; these two were
removed from our dataset. Finally, the same sequence identity
filtering was run (as described earlier for the E2 dataset): in this
step, 10 proteins with more than 85% identity to another better
annotated protein in the dataset were deleted. At the end of all
these steps, 451 E3 sequences remained. The classification of E3s
into families was adopted from the literature and KEGG BRITE
database [11,23,24] (Table S8, cf. also Table 1).
Collecting human E3 data from the literature
Based on sequence similarity criteria and the presence of
characteristic domain signatures, 617 E3 proteins have been
identified in the human genome so far [11]. 309 of these are
RING finger/U-box proteins, of which only 250 are well studied
experimentally [4]. Out of these 250 high-confidence RING/U-
box E3s, we could successfully assign UniProt IDs to 249 E3s.
Next, identical proteins (from amongst these 249) were removed
by filtering for identical UniProt IDs, and 240 unique UniProt IDs
were retained. Since we were interested only in human proteins,
we replaced one rat protein with its human homologue and
deleted three mouse proteins (with no identified homologues in
human). We also deleted three further entries because their IDs
were removed from UniProt since publication of the van Wijk et al
[4] collection of E3 proteins. Finally, we used the CD-HIT
algorithm to remove sequences above 85% sequence identity.
Application of all these filtering criteria resulted in 219 well-
annotated human RING finger/U-box E3 proteins (Table S9).
Merging E3 proteins retrieved from KEGG database and
literature
We felt the need to create a carefully annotated (and updated)
dataset of human E1, E2 and E3s. Although the previously
published list of 617 predicted E3s [11] is considered a classical
paper in the field, not all of those proteins have been characterized
as bona fide E3s (particularly, as some of them do not have
detectable binding to any E2). Therefore, in this work, we attempt
to bridge the gap between predicted E3 sets (compiled on the basis
of sequence and structural homology matches), and known
experimental evidence from the literature and also from databases
that employ manual curation. The basic difference between the
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two parallel E3 datasets (described in the two earlier sections) is
that data in the KEGG BRITE database [23–25] are manually
curated based on experimental information in the literature,
whereas the dataset based on reference [4] contain predicted E3
ligases identified based on sequence similarity/motif patterns.
Therefore, to obtain a single, comprehensive and well-annotated
database of human E3 proteins, we decided to carefully merge
these two datasets (Figure S1). Of the 161 and 212 sRFs from the
KEGG and literature-based [4] sets respectively, 91 were in
common. All 4 U-box and 3 mRF proteins in the literature set
were also found in KEGG. After merging, we repeated the 85%
sequence identity filtering, which identified 9 highly similar
sequences; these were removed. To summarize, our composite
dataset contained sequence data for 305 HECT/RING-finger/U-
box E3s (302 ssE3s and 3 mRFs) and 258 adaptor/substrate
recognition E3s (563 in total; for the number in different families,
cf. also Table 1 and Figure 1), alongside 2 E1 and 29 E2s (Table
S2 and Table S3).
Prediction of structural disorder
We used the IUPred method [88,89] for predicting structural
disorder in all the sequences in our database. IUPred returns a
disorder score between 0.0 and 1.0 for every residue in the
sequence; a value $0.5 indicates local structural disorder. From
residue-specific scores, we calculated several global measures of
disorder for the proteins, such as the number and ratio of their
disordered residues (the latter referred to as disorder content), and
the length of their longest consecutive disordered segment. We also
counted proteins, which have at least one long disordered region
($30 consecutive residues) ignoring short intervening ordered
regions not longer than three consecutive residues. Proteins were
considered mostly ordered (O) if the ratio of their disordered
residues was less than 0.5; otherwise they were considered mostly
disordered (D) (Tables S1, S2 and S3). To calculate the mean of
any of the measures determined, we averaged the individual values
without using any weighting. We also re-calculated the disorder
content using two other standard predictors, FoldIndex [27] and
DisProt-VSL2 [90], to test if (and to what extent) the results
depend on the nature of the predictor(s) used. Unless explicitly
specified, the predicted disorder results correspond to calculations
performed using IUPred.
Interaction classification
We collected interaction data for all 563 E3s from two different
sources (Tables S2 and S3). First, we used the results of a large-
scale analysis of binary interactions between RING finger/U-box
E3s and UBC domain containing E2s [4] which reported physical
interactions between 104 E3s and 20 E2s (Table S9). Second, we
extracted known interactions from the STRING database for all
E3s [91] with a confidence score set to 0.7 (high confidence
interactions). We studied the connectivity (‘k’) of E3s and grouped
them as hubs (H, k$25), intermediately connected proteins (ICP,
4#k#24) and non-hubs (NH; k#3) [92] based on the number of
their reported interaction partners (Tables S2 and S3).
Collection of structural information on E3 interactions
We collected all the distinct (by 95% sequence identity filter)
structures from the PDB database [93] in which a human E3
ubiquitin ligase is in complex with any other human protein. The
interactions found are listed in Table S6.
Definition of linker regions in sRF and U-box E3 ligases
We downloaded the complete UniProt annotation for the 280
sRF and U-box E3 ligases present in our database. 36 proteins
were excluded from the linker analysis due to the lack of any
RING/U-box domains in their UniProt feature table annotation.
In case of 91 E3s the RING/U-box domain was the only domain
annotated by UniProt; since the region responsible for substrate
recognition could not be defined precisely in these proteins, they
were discarded from the linker analysis. For the remaining
proteins the non-RING/U-box domains were collected and they
were categorized as potential substrate recognition or non-
substrate recognition domains based on extensive literature mining
and information provided by protein domain family databases. 23
potential substrate recognition domains were identified. All those
regions were accepted as linkers, which are located between a
RING/U-box domain and an adjacent potential substrate
recognition domain and are not interrupted by any other domain
or transmembrane region. At the end 90 such linkers could be
identified, which were subject to length distribution and disorder
content analysis.
Tests of statistical significance
Mann-Whitney U-tests were used for calculating statistical
significance of observed differences between different groups. This
test was applied because it is a non-parametric test that does not
make any assumptions about the normality of the datasets being
compared. The implementation as available in the R package
(http://www.R-project.org/) was used. Comparisons between E1s
and the other classes were not performed because there were only
2 E1 proteins. Within the E3 sub-classes, the U-box and mRF
families were also not used for statistical comparisons because of
the paucity of family members (6 and 3 proteins, respectively).
Normal-mode analysis
Normal mode analysis was performed on the PDB structure
4A4C. This multi-protein complex comprises the tyrosine kinase
binding (TKB) domain, linker helix region and the RING domain
of a single-subunit E3 (human CBL), bound to its cognate E2
(UbcH5B) and a 12-residue peptide derived from the CBL
substrate ZAP-70 tyrosine kinase. Coarse-grained normal-mode
analysis (NMA) was performed using the elNe´mo web server [94].
The coarse-grained elastic network model provides reliable
descriptions of long-range, concerted conformational dynamics
[95]. In this approach the concerted motions are calculated within
the quasi-harmonic approximation of the free energy around a
protein’s native state (assumed to coincide with the energy-
minimized model obtained from the starting crystal structure). The
RTB (rotations-translations of blocks) approach [96] implemented
in elNe´mo was used. This construction represents each residue as a
rigid block, and translations/rotations between blocks defines the
motions of the system. Eliminating the first six frequencies
(corresponding to three rotational and three translational move-
ments of the whole system), we studied the CG-NMA results from
the lowest five non-trivial modes. To overcome potential biases
due to starting from a single initial configuration, the ENM was
built and the normal modes calculated using three different
conformations (the initial x-ray configuration, and two different
snapshots selected from a MD simulation (see following section)).
The two MD snapshots (at 32 and 25 ns) used for repeating the
NMA correspond respectively to an ‘‘open’’ and a ‘‘closed’’
structural state of the complex as obtained from a clustering of the
structure configurations from the entire MD trajectory.
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Molecular Dynamics simulation
Even though normal mode calculations are powerful in
obtaining long-range movements such as inter-domain motions,
molecular dynamics (MD) simulations are useful to have atomic-
level details. Therefore, we performed all-atom, explicit solvent
MD simulation of the 4A4C protein complex. First, an incomplete
residue (Chain C: Thr129) of a surface loop was built into the
structure using the SuperLooper prediction server [97], and
missing side chain atoms were modeled using the WHAT IF server
[98]. Next, molecular dynamics (MD) simulations were performed
with the Gromos96 43a1p [99] force field as implemented in
GROMACS 4.5.4 [100]. This forcefield includes entries for
phosphorylated residues, which were required as the 4A4C
structure includes two phospho-tyrosine residues, including pTYR
371 on the CBL ligase, that functions as an important
conformational switch and primes the E3 for catalysis [49]. The
models were solvated using simple point charge water molecules in
a cubic box with a minimum distance of 10A˚ from the edge of the
box to any protein atom. Adding chloride ions neutralized the net
charge of the system. To eliminate unfavorable contacts and steric
overlaps, the solvated system was minimized using the steepest-
descent method. Then the system was heated from 0 to 300 K in
100 ps constraining protein atoms to allow for the relaxation of
solvent molecules. Production simulations were performed for
50 ns with the NPT ensemble at 300 K and room pressure.
Temperature and pressure were controlled using the modified
Berendsen thermostat [101] and Parrinello-Rahman barostat
respectively, as implemented in Gromacs. The system was
simulated under periodic boundary conditions with cutoffs of 10
A˚ each for electrostatic and van der Waals terms. The long-range
electrostatic interactions were calculated with Particle Mesh Ewald
summation. Initial velocities were generated randomly from a
Maxwell distribution at 300 K in accordance with the masses
assigned to the atoms. During the production runs, a time step of 2
fs was used in the Leapfrog algorithm, and the LINCS algorithm
[102] was used to constrain all bond lengths except those in water
molecules. Simple harmonic distance restraints to the coordinating
residues were applied to keep the metal ions (2 Zinc and 1
Calcium) in their correct positions in the structure. Coordinates
were recorded every 2 ps. Structural alignments and figure
rendering were performed using PyMol [103].
Supporting Information
Table S1 Contains information regarding E1s and E2s and all
disorder related calculations performed
(XLS)
Table S2 All information regarding 305 E3s, for which data
have been collected from the literature and KEGG database, and
also all calculated data related to disorder and connectivity are
included.
(XLS)
Table S3 All information regarding 258 adaptor proteins, for
which data have been collected from KEGG database and all
calculated results, related to disorder and connectivity are
included.
(XLS)
Table S4 Mean disorder content for E1, E2 and E3 families
predicted using three different predictors.
(DOC)
Table S5 Mean disorder content and connectivity level for
Hubs, intermediately connected proteins and NonHubs for
different families of E3s.
(XLS)
Table S6 List of PDB structures showing E3 ligase interactions
with human partners.
(DOC)
Table S7 Whole set of E3s downloaded from KEGG.
(DOC)
Table S8 Collection of well-studied E3s from KEGG.
(DOC)
Table S9 All E3s obtained from the literature.
(DOC)
Figure S1 Merging E3 datasets obtained from KEGG-
BRITE database and literature. Schematic illustration of the
merging of the different categories of E3 ligases obtained from the
KEGG-BRITE database and by literature mining. The principal
categories of E3 proteins are shown at the top, and the number
collected for each category provided below (blue and red circles
represent the number of proteins extracted from KEGG and
literature sources, respectively). The number of proteins common
between the two sets is shown within the intersecting region. The
second row of circles shows the number of proteins in each group
after merging the datasets. All proteins in each category are then
pooled together, followed by the 85% sequence identity filtering,
to obtain the final set of 563 E3 enzymes (detailed description of
each step is provided in the Methods section).
(TIF)
Figure S2 Analysis of long disordered regions (LDRs).
(A) Fraction of disordered residues present within Long Disordered
Regions (LDRs). This value is calculated as nLDR/Ntot, where,
nLDR is the number of residues present within LDRs, and Ntot is
the protein length. This ratio (expressed as a percentage) is
calculated for each protein, and the distribution is plotted here.
The bars represent E3 ligases, whereas the smooth line represents
the data for the human proteome (as done in Figure 2A). (B)
Abundance of LDRs in E3 ligases (compared to the occurrence of
LDRs in the human proteome). The final bin in this histogram
corresponds to proteins with 10 or more LDRs within their
sequence.
(TIF)
Figure S3 Analysis of properties of inter-domain linkers
linking adjacent E2-binding and substrate/adaptor
binding domains in RING and U-box ssE3s. (A) Length
distribution (last bin corresponds to 3 proteins being longer than
450 residues). (B) Average disorder score in linker region (Scores
calculated by IUPred).
(TIF)
Supplementary Zip Files S1 Animated gif image files (labelled
4A4C_nm1.gif to 4A4C_nm5.gif) showing the normal mode
transitions along the lowest frequency normal modes 1 to 5. In
these movies, the E3 ligase (c-CBL) is in blue cartoon
representation, the E2 in grey colored surface representation (with
the catalytic CYS85 in yellow), and the substrate peptide in red
VDW representation.
(ZIP)
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